請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/1295
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林先和(Hsien-Ho Lin) | |
dc.contributor.author | Wei-Cheng Lo | en |
dc.contributor.author | 羅偉成 | zh_TW |
dc.date.accessioned | 2021-05-12T09:35:44Z | - |
dc.date.available | 2018-02-22 | |
dc.date.available | 2021-05-12T09:35:44Z | - |
dc.date.copyright | 2018-02-22 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-02-08 | |
dc.identifier.citation | 參考文獻
1. Murray CJ: Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World health Organization 1994, 72:429. 2. Murray CJ, Lopez AD, Jamison DT: The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bulletin of the World Health Organization 1994, 72:495. 3. Steel N: Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390:1151-1210. 4. Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, Aboyans V: Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet 2017, 390:1260-1344. 5. Hay S: Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. 2017. 6. Bennett D, Bisanzio D, Deribew A, Gething P, Hay S, Ali R: Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. 2017. 7. Iburg KM: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390:1345-1422. 8. Murray CJ, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-Raddad LJ: Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet 2015, 386:2145-2191. 9. Kassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A, Casey DC, Charlson FJ, Coates MM, Coggeshall M: Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet 2016, 388:1603-1658. 10. Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N, et al: Disability weights for the Global Burden of Disease 2013 study. Lancet Global Health 2015, 3:E712-E723. 11. United Nations: Draft outcome document of the United Nations summit for the adoption of the post-2015 development agenda. Sixty-ninth session of the General Assembly of the United Nations. New York: United Nations; 2015. 12. Fullman N, Barber RM, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abera SF: Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet 2017, 390:1423-1459. 13. Lim SS, Fullman N, Murray CJ, Mason-Jones AJ: Measuring the health-related Sustainable Development Goals in 188 countries:: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet 2016:1-38. 14. Abraham D. Flaxman TV, and Christopher J.L. Murray: An Integrative Metaregression Framework for Descriptive Epidemiology. 2015. 15. Chan M: From new estimates to better data. Lancet 2012, 380:2054-2054. 16. 林先和: 建立我國失能調整人年統計標準作業模式之研究. Taiwan; 2014. 17. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, et al: Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386:2287-2323. 18. Household and Business Energy Consumption Survey, Taiwan. Chung-Hua Institution for Economic Research; 1995. 19. Wu Y-C: Disease burden and attributable risk factors of stroke in Taiwan, 2007 to 2012. In 143rd APHA Annual Meeting and Expo (Oct 31-Nov 4, 2015). Chicago: APHA; 2015. 20. Begg SJ, Vos T, Barker B, Stanley L, Lopez AD: Burden of disease and injury in Australia in the new millennium: Measuring health loss from diseases, injuries and risk factors. Medical Journal of Australia 2008, 188:36-40. 21. Christie S, Tobias M: The burden of infectious disease in New Zealand. Australian and New Zealand Journal of Public Health 1998, 22:257-260. 22. Gane EJ, Brunton CR, Estes C, Henderson C, Hornell J, Radke S, Razavi H, Stedman CA: Hepatitis C Virus (HCV) Infection in New Zealand: Burden of Chronic Disease. Hepatology 2014, 60:913a-914a. 23. He M, Ma J, Wang D, Chang J, Yu X: The Disease Burden Analysis of 295 Inpatients with Diabetes Mellitus from Tongji Hospital in China. Value in Health 2010, 13:A527-A527. 24. Kumagai Y, Gilmour S, Ota E, Momose Y, Onishi T, Bilano VLF, Kasuga F, Sekizaki T, Shibuya K: Estimating the burden of foodborne diseases in Japan. Bulletin of the World Health Organization 2015, 93:540-549. 25. Park MS, Kim YS, Lee SH, Kim SH, Park KH, Bahk GJ: Estimating the Burden of Foodborne Disease, South Korea, 2008-2012. Foodborne Pathogens and Disease 2015, 12:207-213. 26. Phua HP, Chua AVL, Ma S, Heng D, Chew SK: Singapore's burden of disease and injury 2004. Singapore Medical Journal 2009, 50:468-478. 27. Wei L, Wang Y, Feng GS, Yu SC, Duan ZP, Lee MH, Rao HY, Li H: Evaluation of disease burden of hepatitis C in China. Journal of Clinical Virology 2015, 69:231-231. 28. GBD Risk Factors Collaborators: Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388:1659-1724. 29. Levin ML: The occurrence of lung cancer in man. Acta-Unio Internationalis Contra Cancrum 1953, 9:531-541. 30. Rockhill B, Newman B, Weinberg C: Use and misuse of population attributable fractions. American journal of public health 1998, 88:15-19. 31. Miettinen OS: Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974, 99:325-332. 32. Spiegelman D, Hertzmark E, Wand H: Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes & Control 2007, 18:571-579. 33. Liao SF, Yang HI, Lee MH, Chen CJ, Lee WC: Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan. PLoS One 2012, 7:e34779. 34. Liao S-F, Lee W-C: Weighing the causal pies in case-control studies. Annals of epidemiology 2010, 20:568-573. 35. 衛生福利部: 中華民國105年死因統計. 衛生福利部; 2017. 36. 梁玲郁: 測量台灣地區主要疾病之失能及健康餘命之研究. 行政院衛生署; 2010. 37. 梁玲郁: 測量台灣地區主要死因疾病之失能及健康餘命之研究. 行政院衛生署; 2011. 38. 楊銘欽: 我國主要非傳染病之疾病負擔及經濟衝擊評估. 衛生福利部國民健康署; 2014. 39. 楊銘欽: 104年度「國民疾病負擔資料庫及指標建置計畫」. 衛生福利部; 2015. 40. 楊銘欽: 105年度「國民疾病負擔資料庫及指標建置計畫」. 衛生福利部; 2016. 41. 李中一, 胡淑貞, 王亮懿, 邱靜如, 莊佳蓉, 盧豐華, 王榮德, 古鯉榕, 吳晉祥, 劉介宇: 建構領航國際之活躍老化監測暨決策支援系統-資料庫整合與加值分析暨專案管理計畫 (104-107年). 衛生福利部國民健康署; 2015. 42. Chang YC, Chiu YF, Lee IT, Ho LT, Hung YJ, Hsiung CA, Quertermous T, Donlon T, Lee WJ, Lee PC, et al: Common ALDH2 genetic variants predict development of hypertension in the SAPPHIRe prospective cohort: gene-environmental interaction with alcohol consumption. BMC Cardiovasc Disord 2012, 12:58. 43. Levy DT, Wen CP, Chen TY, Oblak M: Increasing taxes to reduce smoking prevalence and smoking attributable mortality in Taiwan: results from a tobacco policy simulation model. Tob Control 2005, 14 Suppl 1:i45-50. 44. Liaw KM, Chen CJ: Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tob Control 1998, 7:141-148. 45. Wang WS, Wahlqvist ML, Hsu CC, Chang HY, Chang WC, Chen CC: Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health 2012, 12:111. 46. Wen CP, Chan HT, Tsai MK, Cheng TY, Chung WS, Chang YC, Hsu HL, Tsai SP, Tsao CK, Man Wai JP, Hsu CC: Attributable mortality burden of metabolic syndrome: comparison with its individual components. Eur J Cardiovasc Prev Rehabil 2011, 18:561-573. 47. CDC: Taiwan Tuberculosis Control Report 2015. Taiwan: Centers for Disease Control; 2017. 48. Donald PR, van Helden PD: The global burden of tuberculosis--combating drug resistance in difficult times. N Engl J Med 2009, 360:2393-2395. 49. WHO: Global tuberculosis report 2016. 2016. 50. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC: Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010, 375:1814-1829. 51. World Health Report: Reducing risks, promoting healthy life. Geneva: World Health Organization; 2002. 52. National Health Interview Survey [http://nhis.nhri.org.tw/2009nhis.html (in Chinese)] 53. TWEPA. Taiwan Air Quality Mornitoring Network. [http://taqm.epa.gov.tw/taqm/en/YearlyDataDownload.aspx] 54. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Jr., Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS: 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc 2011, 43:1575-1581. 55. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR, Jr., Schmitz KH, Emplaincourt PO, et al: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:S498-504. 56. Bull FC AT, Dixon T, Ham S, Neiman A, et al. : Physical inactivity. In Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors (Ezzati M LA, Rodgers A, Murray CJL ed. pp. 729-881. World Health Organization: Geneva; 2004:729-881. 57. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K: Alcohol and coronary heart disease: a meta-analysis. Addiction 2000, 95:1505-1523. 58. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260. 59. Ezzati M, Henley SJ, Thun MJ, Lopez AD: Role of smoking in global and regional cardiovascular mortality. Circulation 2005, 112:489-497. 60. National Lung Screening Trial Research: Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409. 61. National Health Interview Survey. [http://nhis.nhri.org.tw/2005nhis.html (in Chinese)] 62. Nakagami H, Murakoshi C, Iwafune Y: International comparison of household energy consumption and its indicator. Proceedings of the 2008 ACEEE Summer Study on Energy Efficiency in Buildings 2008:214-224. 63. Wen CP, Tsai SP, Chen CJ, Cheng TY, Tsai MC, Levy DT: Smoking attributable mortality for Taiwan and its projection to 2020 under different smoking scenarios. Tob Control 2005, 14 Suppl 1:i76-80. 64. Monthly Bulletin of Interior Statistics: Monthly Bulletin of Interior Statistics. vol. 1.7 Population for Township and District and by Urban Area. Taipei, Taiwan: Statistics Department, Ministry of the Interior; 2014. 65. Foreman KJ, Naghavi M, Ezzati M: Improving the usefulness of US mortality data: new methods for reclassification of underlying cause of death. Population Health Metrics 2016, 14. 66. Luh K, Chiang C, Lee J, Wang J, Wang K, Yu M, Lee P, Lee P, Lin H, Chiang I: Taiwan guidelines for TB diagnosis and treatment. Taipei, Taiwan: Centers for Disease Control, ROC (Taiwan) 2011. 67. Lo HY, Yang SL, Chou P, Chuang JH, Chiang CY: Completeness and timeliness of tuberculosis notification in Taiwan. Bmc Public Health 2011, 11. 68. Ezzati M, Henley SJ, Lopez AD, Thun MJ: Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer 2005, 116:963-971. 69. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M: The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009, 6:e1000058. 70. WHO: Review of areca (betel) nut and tobacco use in the Pacific: a technical report. 2012. 71. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Jr.: Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992, 339:1268-1278. 72. World Health Organization. Regional Office for Europe: Air quality guidelines: global update 2005: particulate matter, ozone, nitrogen dioxide, and sulfur dioxide. World Health Organization; 2006. 73. Burnett RT, Pope CA, 3rd, Ezzati M, Olives C, Lim SS, Mehta S, Shin HH, Singh G, Hubbell B, Brauer M, et al: An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ Health Perspect 2014, 122:397-403. 74. Yu HL, Wang CH: Retrospective prediction of intraurban spatiotemporal distribution of PM2.5 in Taipei. Atmospheric Environment 2010, 44:3053-3065. 75. Ott JJ, Stevens GA, Groeger J, Wiersma ST: Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012, 30:2212-2219. 76. Lai MS, Hsieh MS, Chiu YH, Chen THH: Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006, 43:1295-1302. 77. Wen CP, Tsai SP, Chen CJ, Cheng TY: The mortality risks of smokers in Taiwan: Part I: cause-specific mortality. Prev Med 2004, 39:528-535. 78. Ikeda N, Inoue M, Iso H, Ikeda S, Satoh T, Noda M, Mizoue T, Imano H, Saito E, Katanoda K, et al: Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med 2012, 9:e1001160. 79. Puddey IB, Rakic V, Dimmitt SB, Beilin LJ: Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors--a review. Addiction 1999, 94:649-663. 80. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G, C GBMRF: Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014, 383:970-983. 81. Lu Y, Hajifathalian K, Rimm EB, Ezzati M, Danaei G: Mediators of the Effect of Body Mass Index on Coronary Heart Disease Decomposing Direct and Indirect Effects. Epidemiology 2015, 26:153-162. 82. Danaei G, Rimm EB, Oza S, Kulkarni SC, Murray CJ, Ezzati M: The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Med 2010, 7:e1000248. 83. Ezzati M, Hoorn SV, Lopez AD, Danaei G, Rodgers A, Mathers CD, Murray CJL: Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors. In Global Burden of Disease and Risk Factors. Edited by Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Washington (DC); 2006 84. Murray CJ, Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S: Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr 2003, 1:1. 85. Dagostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB: Relation of Pooled Logistic-Regression to Time-Dependent Cox Regression-Analysis - the Framingham Heart-Study. Statistics in Medicine 1990, 9:1501-1515. 86. Lienhardt C: From exposure to disease: The role of environmental factors in susceptibility to and development of tuberculosis. Epidemiologic Reviews 2001, 23:288-301. 87. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M: Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Social Science & Medicine 2009, 68:2240-2246. 88. Brunekreef B, Holgate ST: Air pollution and health. The lancet 2002, 360:1233-1242. 89. Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ: Cardiovascular mortality and long-term exposure to particulate air pollution. Circulation 2004, 109:71-77. 90. Rabl A: Interpretation of air pollution mortality: number of deaths or years of life lost? Journal of the air & waste management association 2003, 53:41-50. 91. King G, Tomz M, Wittenberg J: Making the Most of Statistical Analyses: Improving Interpretation and Presentation. American Journal of Political Science 2000, 44:341–355. 92. Lu TH, Hsu PY, Bjorkenstam C, Anderson RN: Certifying diabetes-related cause-of-death: a comparison of inappropriate certification statements in Sweden, Taiwan and the USA. Diabetologia 2006, 49:2878-2881. 93. Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, Bixby H, Cowan MJ, Ali MK, Taddei C, et al: Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016, 387:1513-1530. 94. Ministry of Health and Welfare, Taiwan: 2016 Taiwan tobacco control annual report. Executive Yuan, Taipei: Health Promotion Administration 2017. 95. Sung HY, Chang LC, Wen YW, Tsai YW: The costs of smoking and secondhand smoke exposure in Taiwan: a prevalence-based annual cost approach. BMJ Open 2014, 4:e005199. 96. Health Promotion Administration Annual Report: 2014 Health Promotion Administration Annual Report. Taiwan: Health Promotion Administration; 2014. 97. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, Assadi R, Bhala N, Cowie B, et al: The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016. 98. Lee C-H, Min-Shan Ko A, Warnakulasuriya S, Ling T-Y, Rajapakse PS, Zain RB, Ibrahim SO, Zhang S-S, Wu H-J, Liu L: Population burden of betel quid abuse and its relation to oral premalignant disorders in South, Southeast, and East Asia: an Asian Betel-quid Consortium Study. American journal of public health 2012, 102:e17-e24. 99. Chen DS: Hepatocellular carcinoma in Taiwan. Hepatol Res 2007, 37 Suppl 2:S101-105. 100. Chu DA, Kaufman Y, Zibordi G, Chern J, Mao J, Li C, Holben B: Global monitoring of air pollution over land from the Earth Observing System‐Terra Moderate Resolution Imaging Spectroradiometer (MODIS). Journal of Geophysical Research: Atmospheres 2003, 108. 101. Gupta P, Christopher SA, Wang J, Gehrig R, Lee Y, Kumar N: Satellite remote sensing of particulate matter and air quality assessment over global cities. Atmospheric Environment 2006, 40:5880-5892. 102. Hutchison KD, Smith S, Faruqui SJ: Correlating MODIS aerosol optical thickness data with ground-based PM 2.5 observations across Texas for use in a real-time air quality prediction system. Atmospheric Environment 2005, 39:7190-7203. 103. Kahn RA, Gaitley BJ, Martonchik JV, Diner DJ, Crean KA, Holben B: Multiangle Imaging Spectroradiometer (MISR) global aerosol optical depth validation based on 2 years of coincident Aerosol Robotic Network (AERONET) observations. Journal of Geophysical Research: Atmospheres 2005, 110. 104. Liu Y, Sarnat JA, Coull BA, Koutrakis P, Jacob DJ: Validation of Multiangle Imaging Spectroradiometer (MISR) aerosol optical thickness measurements using Aerosol Robotic Network (AERONET) observations over the contiguous United States. Journal of Geophysical Research: Atmospheres 2004, 109. 105. Van Donkelaar A, Martin RV, Park RJ: Estimating ground‐level PM2. 5 using aerosol optical depth determined from satellite remote sensing. Journal of Geophysical Research: Atmospheres 2006, 111. 106. Lai TC, Chiang CY, Wu CF, Yang SL, Liu DP, Chan CC, Lin HH: Ambient air pollution and risk of tuberculosis: a cohort study. Occup Environ Med 2016, 73:56-61. 107. EPA US: National Ambient Air Quality Standards for Particulate Matter, Proposed Rule. Federal Register 2012, 77:38889-39055. 108. Fann N, Lamson AD, Anenberg SC, Wesson K, Risley D, Hubbell BJ: Estimating the national public health burden associated with exposure to ambient PM2. 5 and ozone. Risk analysis 2012, 32:81-95. 109. Chen K-S, Lin C, Chou Y-M: Determination of source contributions to ambient PM2. 5 in Kaohsiung, Taiwan, using a receptor model. Journal of the Air & Waste Management Association 2001, 51:489-498. 110. Fang G-C, Chang C-N, Wu Y-S, Fu PP-C, Yang C-J, Chen C-D, Chang S-C: Ambient suspended particulate matters and related chemical species study in central Taiwan, Taichung during 1998–2001. Atmospheric Environment 2002, 36:1921-1928. 111. Hsu Y-C, Lai M-H, Wang W-C, Chiang H-L, Shieh Z-X: Characteristics of Water-Soluble Ionic Species in Fine (PM2. 5) and Coarse Particulate Matter (PM10–2.5) in Kaohsiung, Southern Taiwan. Journal of the Air & Waste Management Association 2008, 58:1579-1589. 112. Chen Y-C, Hsu C-Y, Lin S-L, Chang-Chien G-P, Chen M-J, Fang G-C, Chiang H-C: Characteristics of concentrations and metal compositions for PM2. 5 and PM2. 5–10 in Yunlin County, Taiwan during air quality deterioration. Aerosol Air Qual Res 2015, 15:2571-2583. 113. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR: Risk of tuberculosis from exposure to tobacco smoke - A systematic review and meta-analysis. Archives of Internal Medicine 2007, 167:335-342. 114. Cegielski JP, Arab L, Cornoni-Huntley J: Nutritional Risk Factors for Tuberculosis Among Adults in the United States, 19711992. American Journal of Epidemiology 2012, 176:409-422. 115. Dye C, Trunz BB, Lonnroth K, Roglic G, Williams BG: Nutrition, Diabetes and Tuberculosis in the Epidemiological Transition. Plos One 2011, 6. 116. Harling G, Ehrlich R, Myer L: The social epidemiology of tuberculosis in South Africa: A multilevel analysis. Social Science & Medicine 2008, 66:492-505. 117. Holtgrave DR, Crosby RA: Social determinants of tuberculosis case rates in the United States. American Journal of Preventive Medicine 2004, 26:159-162. 118. Lin HH, Ezzati M, Murray M: Tobacco smoke, indoor air pollution and tuberculosis: A systematic review and meta-analysis. Plos Medicine 2007, 4:173-189. 119. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M: Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet 2008, 372:1473-1483. 120. Lonnroth K, Williams BG, Cegielski P, Dye C: A consistent log-linear relationship between tuberculosis incidence and body mass index. International Journal of Epidemiology 2010, 39:149-155. 121. Lonnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C: Alcohol use as a risk factor for tuberculosis - a systematic review. Bmc Public Health 2008, 8. 122. Muniyandi M, Ramachandran R, Gopi RG, Chandrasekaran V, Subramani R, Sadacharam K, Kumaran R, Santha T, Wares F, Narayanan RR: The prevalence of tuberculosis in different economic strata: a community survey from South India. International Journal of Tuberculosis and Lung Disease 2007, 11:1042-1045. 123. Patra J, Jha P, Rehm J, Suraweera W: Tobacco Smoking, Alcohol Drinking, Diabetes, Low Body Mass Index and the Risk of Self-Reported Symptoms of Active Tuberculosis: Individual Participant Data (IPD) Meta-Analyses of 72,684 Individuals in 14 High Tuberculosis Burden Countries. Plos One 2014, 9. 124. Oh K, Kim H, Kim M: Non-communicable diseases and risk of tuberculosis in Korea. The International Journal of Tuberculosis and Lung Disease 2016, 20:973-977. 125. Soh AZ, Chee CBE, Wang YT, Yuan JM, Koh WP: Alcohol drinking and cigarette smoking in relation to risk of active tuberculosis: prospective cohort study. BMJ Open Respir Res 2017, 4:e000247. 126. Chang M-H, Chen C-J, Lai M-S, Hsu H-M, Wu T-C, Kong M-S, Liang D-C, Shau W-Y, Chen D-S: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New England Journal of Medicine 1997, 336:1855-1859. 127. Chiang C-J, Yang Y-W, You S-L, Lai M-S, Chen C-J: Thirty-year outcomes of the national hepatitis B immunization program in Taiwan. Jama 2013, 310:974-976. 128. Bennett H, Waser N, Johnston K, Kao J-H, Lim Y-S, Duan Z-P, Lee Y-J, Wei L, Chen C-J, Sievert W: A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan. Hepatology international 2015, 9:378-390. 129. Lee M-H, Yang H-I, Yuan Y, L’Italien G, Chen C-J: Epidemiology and natural history of hepatitis C virus infection. World Journal of Gastroenterology: WJG 2014, 20:9270. 130. McEwan P, Ward T, Chen C-J, Lee M-H, Yang H-I, Kim R, L’Italien G, Yuan Y: Estimating the incidence and prevalence of chronic hepatitis C infection in Taiwan using back projection. Value in Health Regional Issues 2014, 3:5-11. 131. Chiang CJ, Yang YW, Chen JD, You SL, Yang HI, Lee MH, Lai MS, Chen CJ: Significant reduction in end‐stage liver diseases burden through the national viral hepatitis therapy program in Taiwan. Hepatology 2015, 61:1154-1162. 132. Lee P-H, Fu H, Lai T-C, Chiang C-Y, Chan C-C, Lin H-H: Glycemic control and the risk of tuberculosis: a cohort study. PLoS medicine 2016, 13:e1002072. 133. United Nations: Transforming our world: the 2030 Agenda for Sustainable Development Seventieth session of the General Assembly of the United Nations. [cited 2016 Aprial, 14]; Available from: http://wwwunorg/ga/search/view_docasp?symbol=A/RES/70/1&Lang=E 2015. 134. Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H: WHO's new End TB Strategy. The Lancet 2015, 385:1799-1801. 135. Chen H, Burnett RT, Kwong JC, Villeneuve PJ, Goldberg MS, Brook RD, van Donkelaar A, Jerrett M, Martin RV, Brook JR: Risk of incident diabetes in relation to long-term exposure to fine particulate matter in Ontario, Canada. Environmental health perspectives 2013, 121:804. 136. Lue S-H, Wellenius GA, Wilker EH, Mostofsky E, Mittleman MA: Residential proximity to major roadways and renal function. J Epidemiol Community Health 2013, 67:629-634. 137. Wu Y-C, Lin Y-C, Yu H-L, Chen J-H, Chen T-F, Sun Y, Wen L-L, Yip P-K, Chu Y-M, Chen Y-C: Association between air pollutants and dementia risk in the elderly. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2015, 1:220-228. 138. Rose G: Sick individuals and sick populations. International journal of epidemiology 2001, 30:427-432. 139. 行政院衛生福利部: 2025衛生福利政策白皮書. 行政院衛生福利部; 2016. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/handle/123456789/1295 | - |
dc.description.abstract | 透過健康介入政策達到有效控制或預防引起慢性疾病的危險因子是促進國人健康的關鍵,為了擬定合適且正確的健康介入政策,首先必須瞭解各種可預防或可介入的危險因子對於國家整體的罹病風險或是死亡所佔的角色與重要性。
藉由台灣豐富的健康資料,本研究利用比較性風險評估(Comparative Risk Assessment, CRA)的架構推估及比較多個可預防或可介入危險因子對國人慢性非傳染病死亡負擔的影響,評估的危險因子包括血壓過高、血糖過高、血脂過高、肥胖、吸菸、飲酒、嚼檳榔、缺乏運動、PM2.5暴露、高鈉攝取、低蔬果飲食攝取與慢性B型肝炎和C型肝炎感染。另一方面,本研究亦透過健康資料的連結,建立一具族群代表性之研究世代並藉由部分族群可歸因分率(Partial Population Attributable Fraction, PAFp)與因果圓派加權模型(causal pie weighted model)的分析來評估抽菸、飲酒、糖尿病以及體重過輕等危險因子對台灣結核病疫情的影響。 分析結果顯示血糖過高、吸菸、血壓過高是造成國人死亡負擔最重要的危險因子,2009年約有14,900名死亡人口與血糖過高有關,其次是吸菸,影響了13,340名死亡人口,而血壓過高,分別貢獻約6,280名男性死亡人口以及4,910名女性死亡人口。而評估PM2.5暴露相關的死亡負擔也發現顯著的地區別差異,說明健康不平等議題的重要性以及多層次的預防介入計畫的必要性。在結核病負擔的評估上,考量危險因子的相關性並調整年齡、性別與其他社經地位因子後,部分族群可歸因分率估計結果發現有38.2%的結核病發生與吸菸、飲酒、糖尿病以及體重過輕有關,進一步利用因果圓派加權模型考量這些危險因子的交互作用發現,有15.8%的結核病發生來自吸菸與飲酒兩者並存的影響。 本研究提供了危險因子對於國人整體健康影響的量化評估證據,未來可結合成本效益分析,在資源有限之情形下,幫助衛生健康資源分布的政策依據參考。另外,本研究結果亦指出未來的疾病預防與健康促進必須有更多的跨部門、跨面向的合作與規劃,與聯合國提出的永續發展目標一致,強調政策擬定上多元整合的重要性。 | zh_TW |
dc.description.abstract | To facilitate priority-setting in health policymaking and be best to allocate public health resources, we estimated the adult mortality burden attributable to 13 metabolic, lifestyle, infectious, and environmental risk factors in Taiwan. Also, for communicable disease, the impact of modifiable risk factors (tobacco smoking, alcohol use, underweight, and diabetes mellitus) on tuberculosis incidence was estimated individually and jointly.
Taking advantage of the well-established health information system in Taiwan, the comparative risk assessment framework was applied to estimate mortality burden of non-communicable diseases attributable to individual risk factor or risk factor clusters, while a national representative cohort was built up for quantifying the joint impact of these potentially modifiable risk factors on tuberculosis in Taiwan. We found high blood glucose, tobacco smoking, and high blood pressure are the major risk factors for deaths from non-communicable diseases and injuries among Taiwanese adults. In 2009, high blood glucose accounted for 14,900 deaths (95% UI: 11,850–17,960). It was followed by tobacco smoking (13,340 deaths, 95% UI: 10,330–16,450), and high blood pressure (11,190 deaths, 95% UI: 8,190–14,190). A large number of years of life would be gained if the 13 modifiable risk factors could be removed or reduced to the optimal level. Also, the substantial geographic variation in PM2.5 attributable mortality fraction was found. The social inequalities in environment and health deserve more attentions. For the burden of tuberculosis incidence, the analysis of partial population attributable fraction found that tobacco smoking, alcohol consumption, underweight, and diabetes mellitus individually contributed 18.5%, 12.7%, 6.7%, and 7.5%, respectively, and jointly accounted for 38.2% (95% CI 19.6%, 54.1%) of TB cases in Taiwan. On the other hand, a significant interactive effect due to tobacco smoking and alcohol consumption was identified by causal pie weighted model; there are 15.8% of TB cases caused by the interaction between tobacco smoking and alcohol consumption. Our integrative analysis provides an aerial view of distribution and determinants of population health and helps the country to prepare for the new Sustainable Development Goals. Our findings underline the necessity to intensify the collaborative effort from the communicable and non-communicable health sectors as well as non-health sectors. | en |
dc.description.provenance | Made available in DSpace on 2021-05-12T09:35:44Z (GMT). No. of bitstreams: 1 ntu-107-D01849006-1.pdf: 3172721 bytes, checksum: 063be510db5b854f6dd29e5de7f16708 (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 目錄
口試委員會審定書 i 致謝 ii 中文摘要 iii 英文摘要 iv 圖目錄 viii 表目錄 ix 第一章 緒論 1 第一節 研究動機與重要性 1 第二節 重要名詞解釋 2 第二章 文獻探討 5 第一節 全球疾病負擔 5 第二節 比較性風險評估與族群可歸因分率 7 第三節 台灣疾病負擔 11 第四節 危險因子預防與結核病防治 12 第三章 研究目的 13 第四章 材料與方法 14 第一節 研究架構 14 第二節 危險因子的選擇與資料來源 15 第三節 暴露與疾病的定義 17 第四節 相對風險的估計 20 第五節 垃圾死因代碼的再分配 23 第六節 族群可歸因分率 23 第七節 敏感度分析與不確定性估計 27 第五章 結果 29 第一節 慢性非傳染性疾病死亡負擔之比較性風險評估 (2009年) 29 第二節 地區別可歸因於細懸浮微粒(PM2.5)暴露之疾病死亡負擔 (2014年) 43 第三節 可歸因之結核病疾病負擔 49 第六章 討論 57 第一節 台灣族群可歸因疾病負擔分佈情形 57 第二節 全球疾病負擔與台灣疾病負擔 58 第三節 地區別可歸因於細懸浮微粒(PM2.5)暴露之疾病死亡負擔 60 第四節 危險因子介入與結核病控制 62 第五節 慢性非傳染性疾病與慢性傳染性疾病的預防與管理 64 第六節 永續發展目標與世界衛生組織終結結核策略 65 第七節 健康資料的應用與發展 66 第八節 研究優勢與限制 67 第七章 結論與建議 70 第一節 結論 70 第二節 建議 71 參考文獻 74 附錄圖表 88 | |
dc.language.iso | zh-TW | |
dc.title | 台灣族群可歸因於可介入危險因子之疾病負擔 | zh_TW |
dc.title | Burden of Disease Attributable to Modifiable Risk Factors in Taiwan Population | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 詹長權(Chang-Chuan Chan),王英偉(Ying-Wei Wang),賴美淑(Mei-Shu Lai),李文宗(Wen-Chung Lee),江振源(Chen-Yuan Chiang) | |
dc.subject.keyword | 比較性風險評估,族群可歸因分率,疾病負擔,可預防危險因子, | zh_TW |
dc.subject.keyword | comparative risk assessment,population attributable fraction,burden of disease,risk factors prevention, | en |
dc.relation.page | 102 | |
dc.identifier.doi | 10.6342/NTU201800402 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2018-02-08 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf | 3.1 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。